PUMA BIOTECHNOLOGY, INC. Adjustments to Additional Paid in Capital, Other
PUMA BIOTECHNOLOGY, INC. (PBYI) reported Adjustments to Additional Paid in Capital, Other of $61.00 thousand for the 12-month period ending 2011-12-31, per its 10-Q filed 2014-11-10.
Discontinued › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalOther · last filed 2014-11-10
- PUMA BIOTECHNOLOGY, INC. adjustments to additional paid in capital, other for the quarter ending 2011-12-31 was -$983.00, a 114.04% decline year-over-year.
- PUMA BIOTECHNOLOGY, INC. adjustments to additional paid in capital, other for the quarter ending 2010-12-31 was $7.00K.
| Period end | Adjustments to Additional Paid in Capital, Other 3 month | Adjustments to Additional Paid in Capital, Other 4 month | Adjustments to Additional Paid in Capital, Other 9 month | Adjustments to Additional Paid in Capital, Other 12 month | Adjustments to Additional Paid in Capital, Other 12 month as first filed |
|---|---|---|---|---|---|
| 2011-12-31 | -$983.00 derived: 10-Q 12 month − 10-Q 9 month · filed 2014-11-10 | $61.00K 10-Q · filed 2014-11-10 | $61.98K 10-K · filed 2012-03-29 | ||
| 2011-09-30 | $61.98K 10-Q · filed 2011-11-14 | ||||
| 2010-12-31 | $7.00K 10-Q · filed 2014-11-10 | $6.53K 10-Q · filed 2012-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |